Intet billede af Ulrik Niels Lassen

Ulrik Niels Lassen

  • Blegdamsvej 9, 2100 København Ø

1992 …2019

Publikationer pr. år

Netværk

Thomas Urup

  • University of Copenhagen

Ekstern person

Morten Mau-Sørensen

  • University of Copenhagen

Ekstern person

P Dombernowsky

  • University of Copenhagen

Ekstern person

Steinbjørn Hansen

  • University of Southern Denmark

Ekstern person

Jordi Rodon

  • Autonomous University of Barcelona
  • University of Texas MD Anderson Cancer Center

Ekstern person

Vibeke Andrée Larsen

  • University of Copenhagen

Ekstern person

Maria Martinez-Garcia

  • Pompeu Fabra University

Ekstern person

Wolfgang Jacob

  • Roche Diagnostics GmbH

Ekstern person

Martin Weisser

  • Roche Diagnostics GmbH

Ekstern person

Georgina Meneses-Lorente

  • Roche Innovation Center Welwyn

Ekstern person

Francesca Michielin

  • F. Hoffmann-La Roche AG

Ekstern person

Celine Adessi

  • F. Hoffmann-La Roche AG

Ekstern person

Andrés Cervantes

  • Nutrition and Food Science Area

Ekstern person

Morten Mau-Sorensen

  • University of Copenhagen

Ekstern person

Ian R. James

  • A4P Consulting Ltd

Ekstern person

Maurizio Ceppi

  • Roche Diagnostics GmbH

Ekstern person

Mikkel Christian Alanin

  • University of Copenhagen

Ekstern person

Hans-Georg Rammensee

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Lise Barlebo Ahlborn

  • Kobenhavns Universitet

Ekstern person

Francisco Martínez-Ricarte

  • Autonomous University of Barcelona

Ekstern person

Norbert Hilf

  • Immatics Biotechnologies GmbH

Ekstern person

Bracha Shraibman

  • Technion-Israel Institute of Technology

Ekstern person

Kenneth Francis Hofland

  • University of Copenhagen

Ekstern person

Sabrina Kuttruff-Coqui

  • Immatics Biotechnologies GmbH

Ekstern person

Berta Ponsati

  • BCN Peptides

Ekstern person

Sebastian Kreiter

  • BioNTech Ag
  • working group Cancer Immunoguiding Program

Ekstern person

Camilla Klausen

  • University of Copenhagen
  • Copenhagen University Hospital, Hvidovre

Ekstern person

Ghazaleh Tabatabai

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Sjoerd H. van der Burg

  • working group Cancer Immunoguiding Program
  • Leiden University

Ekstern person

Katrin Frenzel

  • BioNTech Ag
  • Neuruppin Bonn

Ekstern person

Pierre Yves Dietrich

  • University of Geneva

Ekstern person

Judith R. Kroep

  • Leiden University

Ekstern person

Valerie Dutoit

  • University of Geneva

Ekstern person

Juan Sahuquillo

  • Autonomous University of Barcelona

Ekstern person

Andreas von Deimling

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

John C. Castle

  • BioNTech Ag
  • Agenus

Ekstern person

Cedrik M. Britten

  • BioNTech Ag
  • working group Cancer Immunoguiding Program
  • GlaxoSmithKline

Ekstern person

Michael Platten

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

Hideho Okada

  • University of California at San Francisco
  • Parker Institute for Cancer Immunotherapy

Ekstern person

Tilde Dombernowsky

  • University of Copenhagen

Ekstern person

Ugur Sahin

  • BioNTech Ag

Ekstern person

Wolfgang Wick

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

Arie Admon

  • Technion-Israel Institute of Technology

Ekstern person

Colette Song

  • Immatics Biotechnologies GmbH

Ekstern person

Christian H. Ottensmeier

  • University of Southampton

Ekstern person

Henrik Pagh Schultz

  • Institut for Klinisk Medicin - Onkologisk Afdeling D, NBG

Ekstern person

Asbjørn Høegholm

  • University of Copenhagen

Ekstern person

Kenneth F. Hofland

  • University of Copenhagen

Ekstern person

Nina Pawlowski

  • Immatics Biotechnologies GmbH

Ekstern person

Mie Grunnet

  • University of Copenhagen

Ekstern person

Catherine J Harmer

  • University of Oxford

Ekstern person

René K Olesen

  • Institut for Klinisk Medicin - Onkologisk Afdeling D, NBG

Ekstern person

Jörg Ludwig

  • Immatics Biotechnologies GmbH

Ekstern person

Iria Gonzalez

  • Pompeu Fabra University

Ekstern person

Klaus Richter Larsen

  • University of Copenhagen

Ekstern person

Stefan Stevanović

  • University of Tübingen
  • German Cancer Research Center

Ekstern person

Annie Moisan

  • F. Hoffmann-La Roche AG

Ekstern person

Claudia Wagner

  • Immatics Biotechnologies GmbH

Ekstern person

Joan Albanell

  • Pompeu Fabra University

Ekstern person

Tjoung-Won Park-Simon

  • Hannover Medical School

Ekstern person

Gregory G. Oakley

  • University of Nebraska Medical Center

Ekstern person

Morten Mau-Sørensen

  • University of Copenhagen
  • Kobenhavns Universitet

Ekstern person

Franziska Hoffgaard

  • Immatics Biotechnologies GmbH

Ekstern person

Lise B Ahlborn

  • University of Copenhagen

Ekstern person

Savvas Kinalis

  • University of Copenhagen

Ekstern person

Per Pfeiffer

  • Onkologi

Ekstern person

Monika Stieglbauer

  • University of Tübingen
  • working group Cancer Immunoguiding Program

Ekstern person

Annika Loft

  • University of Copenhagen

Ekstern person

Sandra Heesch

  • BioNTech Ag

Ekstern person

Christoph Huber

  • BioNTech Ag

Ekstern person

Regina Mendrzyk

  • Immatics Biotechnologies GmbH

Ekstern person

Carsten Reinhardt

  • Immatics Biotechnologies GmbH

Ekstern person

Eric Santoni-Rugiu

  • University of Copenhagen

Ekstern person

Veronique Dieras

  • Institut Curie

Ekstern person

Frederik Marme

  • Heidelberg University 

Ekstern person

Juan Miguel Cejalvo

  • Nutrition and Food Science Area

Ekstern person

Martin R Larsen

  • University of Southern Denmark

Ekstern person

Toni Weinschenk

  • Immatics Biotechnologies GmbH

Ekstern person

Denis Migliorini

  • University of Geneva

Ekstern person

Harpreet Singh-Jasuja

  • Immatics Biotechnologies GmbH

Ekstern person

Lars Rønn Olsen

  • Danmarks Tekniske Universitet

Ekstern person

Jens Fritsche

  • Immatics Biotechnologies GmbH

Ekstern person

Marcus May

  • Hannover Medical School

Ekstern person

Sonja Dorner

  • Immatics Biotechnologies GmbH

Ekstern person

Alexander Ulges

  • Immatics Biotechnologies GmbH

Ekstern person

Carles Codony-Servat

  • Molecular Biology Institute of Barcelona (IBMB)

Ekstern person

Karen-Lise Garm Spindler

  • Onkologisk Afdeling
  • Aarhus University

Ekstern person

Christina W. Yde

  • University of Southern Denmark
  • University of Copenhagen
  • Danish Cancer Society

Ekstern person

Christelle Levy

  • Centre Georges-François Leclerc

Ekstern person

Susanne Keiding

  • Aarhus University Hospital /Aarhus Universitetshospital

Ekstern person

Anders Jakobsen

  • Vejle Hospital

Ekstern person

Silke Engelholm

  • Radiation Medicine Research Center, Department of Radiation Oncology, Rigshospitalet, Copenhagen, Denmark

Ekstern person

Michael Weller

  • University of Zurich

Ekstern person

Arbel D. Tadmor

  • Johannes Gutenberg University Mainz

Ekstern person

Javier Cortés

  • Hospital Ramon y Cajal
  • Autonomous University of Barcelona

Ekstern person

Katharina Kiesel

  • Immatics Biotechnologies GmbH

Ekstern person

David Capper

  • Heidelberg University 
  • German Cancer Research Center
  • Charité – Universitätsmedizin Berlin

Ekstern person

Valesca Bukur

  • BioNTech Ag

Ekstern person

Katy McCann

  • University of Southampton

Ekstern person

Lukas Bunse

  • Heidelberg University 
  • German Cancer Research Center

Ekstern person

C. Le Tourneau

  • Institute Curie, Paris, France Department of Ophtalmology

Ekstern person

Lene Bæksgaard

  • University of Copenhagen

Ekstern person

Morten Mau-Serensen

  • University of Copenhagen

Ekstern person

Marco Skardelly

  • University of Tübingen

Ekstern person

Tomas Racek

  • F. Hoffmann-La Roche AG

Ekstern person

Manja Idorn

  • University of Copenhagen
  • Kobenhavns Universitet

Ekstern person

Miriam Meyer

  • Immatics Biotechnologies GmbH

Ekstern person

Anja Welt

  • University of Duisburg-Essen

Ekstern person

Elisa Rusch

  • University of Tübingen
  • working group Cancer Immunoguiding Program

Ekstern person

Martin Löwer

  • BioNTech Ag

Ekstern person

Markus Hansson

  • Lund University
  • Wallenberg Center for Molecular Medicine

Ekstern person

Jose Lopez-Martin

  • Complutense University

Ekstern person

Oliver Schoor

  • Immatics Biotechnologies GmbH

Ekstern person

Edward Green

  • German Cancer Research Center
  • Heidelberg University 

Ekstern person

Cécile Gouttefangeas

  • University of Tübingen
  • German Cancer Research Center
  • working group Cancer Immunoguiding Program

Ekstern person

Anne Kiil Berthelsen

  • University of Copenhagen

Ekstern person

Wiktor Majewski

  • University of Copenhagen

Ekstern person

Olivier L Chinot

  • Aix-Marseille Université

Ekstern person

Bernhard Rössler

  • Immatics Biotechnologies GmbH

Ekstern person

Alwin D R Huitema

  • Netherlands Cancer Institute
  • Utrecht University

Ekstern person

Florence Joly

  • Centre Georges-François Leclerc

Ekstern person

Marie-Thérése Stockhausen

  • University of Copenhagen

Ekstern person

Max Hasmann

  • Roche Diagnostics GmbH

Ekstern person

Morten Ladekarl

  • Onkologisk Afdeling D, NBG

Ekstern person

Jan Nyrop Jakobsen

  • University of Copenhagen

Ekstern person

Torben Rasmussen

  • University of Southern Denmark

Ekstern person

Jordi Piró

  • BCN Peptides

Ekstern person

Malene Brandt-Larsen

  • University of Copenhagen

Ekstern person

Christoph Schindler

  • Hannover Medical School

Ekstern person

Peter Buhl Jensen

  • University of Copenhagen

Ekstern person